MAPK1 and melanoma: In addition, the use of a BRAFi in combination with OXPHOS inhibitors such as phenformin and gossypol suppressed melanoma cell proliferation indicating that OXPHOS was dependent on the inhibition of the BRAF/MEK/ERK signaling pathway [162].